| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Glibenclamide EP Impurity D |
|
38160-73-5 |
詳細(xì)
|
| Goserelin EP Impurity K Acetate |
|
|
詳細(xì)
|
| Hydrocortisone Acetate EP Impurity E |
|
7753-60-8 |
詳細(xì)
|
| 9α Br Hydrocortisone Acetate |
|
50733-54-5 |
詳細(xì)
|
| Scopolamine EP Impurity B |
|
535-26-2 |
詳細(xì)
|
| Hydroxychloroquine EP Impurity C |
|
4298-15-1 |
詳細(xì)
|
| Ibuprofen Impurity 19/4-(1-Carboxy-ethyl)-Benzoic Acid |
|
67381-50-4 |
詳細(xì)
|
| Ibuprofen EP Impurity N |
|
3585-52-2 |
詳細(xì)
|
| Hydralazine Triazolo Methyl Impurity |
|
20062-41-3 |
詳細(xì)
|
| Hydrocortisone Valerate |
|
57524-89-7 |
詳細(xì)
|
| Hydroxychloroquine O-Acetate |
|
47493-14-1 |
詳細(xì)
|
| Hydroxychloroquine EP Impurity D |
|
1476-52-4 |
詳細(xì)
|
| Hydrocortisone EP Impurity M |
|
566-35-8 |
詳細(xì)
|
| Imatinib EP impurity C |
|
404844-02-6 |
詳細(xì)
|
| Imatinib EP Impurity B |
|
581076-65-5 |
詳細(xì)
|
| Ibrutinib N-Oxide |
|
2417548-74-2 |
詳細(xì)
|
| Ibrutinib Addition Adduct |
|
1987905-93-0 |
詳細(xì)
|
| Ibrutinib Dimer Impurity |
|
2031255-23-7 |
詳細(xì)
|
| Ibrutinib Diamide Impurity |
|
2031255-27-1 |
詳細(xì)
|
| N-Desmethyl Ibandronate |
|
905808-25-5 |
詳細(xì)
|
| 3,4,5-Tris(benzyloxy)benzyl Alcohol |
|
79831-88-2 |
詳細(xì)
|
| N-Fmoc-1-amino-2-methyl-2-propanol |
|
1466611-97-1 |
詳細(xì)
|
| 2,4-Diamino-5-chloro-6-piperidine pyrimidine-3-oxide |
|
2889432-05-5 |
詳細(xì)
|
| 5-Chloro-6-(1-piperidinyl)-2,4-pyrimidinediamine |
|
1784008-01-0 |
詳細(xì)
|
| 2,4-Diamino-5,6-dichloropyrimidine 3-oxide |
|
35139-68-5 |
詳細(xì)
|
| 2,4-Diamino-5,6-dichloropyrimidine |
|
89033-89-6 |
詳細(xì)
|
| Indapamide EP Impurity B |
|
63968-75-2 |
詳細(xì)
|
| Imatinib Impurity 12 |
|
404844-11-7 |
詳細(xì)
|
| Imatinib EP impurity J |
|
571186-91-9 |
詳細(xì)
|
| Imatinib EP Impurity D Chloride |
|
1821122-73-9 |
詳細(xì)
|
| Methyl4-bromo-6-chloronicotinate |
|
1256790-93-8 |
詳細(xì)
|
| Benzo[k]fluoranthene |
|
207-08-9 |
詳細(xì)
|
| (2R,5R)-2,5-Diphenylpyrrolidine |
|
155155-73-0 |
詳細(xì)
|
| 2-Chloro-1-(p-tolyl)ethanone |
|
4209-24-9 |
詳細(xì)
|
| Levetiracetam EP Impurity A |
|
67118-31-4 |
詳細(xì)
|
| (S)-Levetiracetam EP Impurity A |
|
102849-49-0 |
詳細(xì)
|
| Levosimendan Dimer |
|
618458-79-0 |
詳細(xì)
|
| Levosimendan Impurity 6 |
|
220246-81-1 |
詳細(xì)
|
| Levothyroxine EP Impurity H |
|
2055-97-2 |
詳細(xì)
|
| Levothyroxine Acetamide Impurity |
|
176258-88-1 |
詳細(xì)
|
| Ethyl 4-bromo-1-methyl-1H-imidazole-2-carboxylate |
|
1260672-33-0 |
詳細(xì)
|
| 2-Bromo-3-fluoro-4-iodo-pyridine |
|
1804910-90-4 |
詳細(xì)
|
| Isononylphenol |
|
11066-49-2 |
詳細(xì)
|
| Isopropyl2-bromopropanoate |
|
7401-84-5 |
詳細(xì)
|
| (2R,3R,4R,5S)-2,3,4,5,6-pentahydroxyhexyl 4-hydroxybenzoate and (2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl 4-hydroxybenzoate |
|
|
詳細(xì)
|
| 5-Vinylbenzo[d][1,3]dioxole |
|
7315-32-4 |
詳細(xì)
|
| (3b,5b,15a,16a)-15,16-Dihydro-3,5-dihydroxy-3'H-cycloprop[15,16]androsta-6,15-dien-17-one |
|
82543-15-5 |
詳細(xì)
|
| N-Methyl-N’-nitrosopiperazine |
|
16339-07-4 |
詳細(xì)
|
| N,N'-Diphenylethylenediamine |
|
150-61-8 |
詳細(xì)
|
| 1,3-Dibromo-5-(tert-butyl)-2-nitrobenzene |
|
2828612-34-4 |
詳細(xì)
|
| 2-Propenylpropylpropanedioic Acid Diethyl Ester |
|
59726-38-4 |
詳細(xì)
|
| (6S)-5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one 7,7-dioxide |
|
148719-91-9 |
詳細(xì)
|
| Diethyl (2-Oxo-2-phenylethyl)phosphonate |
|
3453-00-7 |
詳細(xì)
|
| Cyclo(-Ala-Gln) |
|
268221-76-7 |
詳細(xì)
|
| (S)-Licarbazepine |
|
104746-04-5 |
詳細(xì)
|
| Latanoprost Lactone Diol |
|
145667-75-0 |
詳細(xì)
|
| Latanoprost EP Impurity D |
|
2088449-88-9 |
詳細(xì)
|
| Isothipendyl HCl |
|
1225-60-1 |
詳細(xì)
|
| Isothipendyl Impurity 1 HCl |
|
132962-42-6 |
詳細(xì)
|
| Ketorolac EP Impurity B |
|
113502-52-6 |
詳細(xì)
|
| (R)-Ketorolac |
|
66635-93-6 |
詳細(xì)
|
| (S)-Ketorolac |
|
66635-92-5 |
詳細(xì)
|
| 5,6-trans-Latanoprost |
|
913258-34-1 |
詳細(xì)
|
| (15S)-Latanoprost |
|
145773-22-4 |
詳細(xì)
|
| 15-Keto Latanoprost |
|
135646-98-9 |
詳細(xì)
|
| Latanoprost Acid |
|
41639-83-2 |
詳細(xì)
|
| 2-Hydroxy-1,4-benzoquinone |
|
2474-72-8 |
詳細(xì)
|
| Lacosamide EP Impurity B |
|
1318777-54-6 |
詳細(xì)
|
| Lamotrigine EP Impurity G |
|
38943-76-9 |
詳細(xì)
|
| Lansoprazole EP Impurity F |
|
168167-42-8 |
詳細(xì)
|
| Lansoprazole Thioxo Impurity |
|
1246819-06-6 |
詳細(xì)
|
| (R)-Licarbazepine Acetate |
|
186694-45-1 |
詳細(xì)
|
| DL-Carnitine |
|
406-76-8 |
詳細(xì)
|
| Lercanidipine Acid |
|
855592-30-2 |
詳細(xì)
|
| Levofloxacin EP Impurity G HCl |
|
1346603-62-0 |
詳細(xì)
|
| Lidocaine EP Impurity D HCl |
|
7729-94-4 |
詳細(xì)
|
| Lidocaine EP Impurity F HCl |
|
857170-72-0 |
詳細(xì)
|
| Lidocaine EP Impurity G HCl |
|
35891-87-3 |
詳細(xì)
|
| Lidocaine EP Impurity I HCl |
|
17289-54-2 |
詳細(xì)
|
| Lidocaine EP Impurity J HCl |
|
1012864-23-1 |
詳細(xì)
|
| Lidocaine EP Impurity K HCl |
|
50295-20-0 |
詳細(xì)
|
| Lidocaine Dichloro Impurity |
|
39084-88-3 |
詳細(xì)
|
| Linezolid N-Oxide |
|
189038-36-6 |
詳細(xì)
|
| N-Boc Linagliptin |
|
668273-75-4 |
詳細(xì)
|
| (S)-Linagliptin |
|
668270-11-9 |
詳細(xì)
|
| Linagliptin N-Acetyl Impurity |
|
1803079-49-3 |
詳細(xì)
|
| Linagliptin Methyl Dimer |
|
1418133-47-7 |
詳細(xì)
|
| Linagliptin Impurity 31 |
|
2253964-85-9 |
詳細(xì)
|
| Lisinopril EP Impurity F |
|
1132650-67-9 |
詳細(xì)
|
| beta-Aspartyl-Aspartic Acid |
|
60079-22-3 |
詳細(xì)
|
| Losartan EP Impurity C |
|
114799-13-2 |
詳細(xì)
|
| Losartan EP Impurity K |
|
114798-36-6 |
詳細(xì)
|
| Loxoprofen Ring-opening Impurity |
|
1091621-61-2 |
詳細(xì)
|
| Lurasidone Aminomethyl Impurity DiHCl |
|
1260025-93-1 |
詳細(xì)
|
| Lurasidone Opened Imide |
|
1644295-07-7 |
詳細(xì)
|
| ent-Lurasidone |
|
1448443-35-3 |
詳細(xì)
|
| Exodiene Lurasidone |
|
3024924-65-7 |
詳細(xì)
|
| Medroxyprogesterone Acetate EP Impurity I |
|
|
詳細(xì)
|
| Cetirizine EP Impurity D |
|
346451-15-8 |
詳細(xì)
|
| Levomedetomidine |
|
119717-21-4 |
詳細(xì)
|